Randomized clinical trials in gastric cancer

Surgical Oncology Clinics of North America

Volumn 11, Issue 1, 2002, Pages 111-131

  Weber, Sharon M ^a,b   Karpeh, Martin S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; SEMUSTINE;

ADJUVANT CHEMOTHERAPY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LYMPHADENECTOMY; METASTASIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; STOMACH CANCER; TOTAL STOMACH RESECTION;

EID: 0036135184     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(03)00077-2     Document Type: Review

References (39)

1. Adjuvant treatments following curative resection for gastric cancer
2. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: Interim report
3. Total versus subtotal gastrectomy: Surgical morbidity and mortality rates in a multicenter Italian randomized trial
4. Extended lymph-node dissection for gastric cancer
5. The concept of locally advanced gastric cancer. Effect of treatment on outcome
6. Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer
7. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer
8. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial
9. Randomized comparison of 5-FU alone or combined with carmustine, doxorubicin, and mitomycin (BAFMi) in the treatment of advanced gastric cancer: A phase III trial of the Italian clinical research oncology group (GOIRC)
10. An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277)
11. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern cooperative oncology group study (EST 3275)
12. Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up
13. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma
14. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
15. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum: A French prospective controlled study
16. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study
17. Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A veterans administration surgical oncology, Group report
18. FAMTX versus etoposide, doxorubicin, and cisplatin: A random assignment trial in gastric cancer
19. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer
20. A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer
21. Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: Implications for future studies
22. Postoperative combined radiation and chemotherapy improves disease-free survival and overall survival in resected adenocarcinoma of the stomach and GE junction
23. A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy
24. Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma
25. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
26. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: A randomised trial
27. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: Effect on prolongation of survival and improvement of quality of life
28. Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. 3- to 6-year follow up of a randomized clinical trial
29. Randomized study of combination chemotherapy in unresectable gastric cancer
30. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer
31. High doses of 5-fluorouracil and epirubicin with or without cisplatin in advanced gastric cancer: A randomized study
32. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer
33. Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma
34. Prophylaxis and treatment of peritoneal carcinomatosis: Intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles
35. Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: Results of a randomized trial
36. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer
37. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin-a step ahead in the treatment of advanced gastric cancer: A trial of the European organization for research and treatment of cancer gastrointestinal tract cooperative group
38. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer
39. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)-Report on 370 patients